FDA nominee Heidi Overton faces Senate committee hearing this morning
Heidi Overton, the Trump administration pick to lead the FDA, is scheduled to appear before a Senate committee today.
State Medicaid pricing initiative status
Trump administration officials recently claimed that every U.S. state agreed to join a federal drug pricing program. Officials stated the initiative aims to lower prices for state Medicaid programs through the GENEROUS model. However, several state officials say they remain undecided about participation despite technically applying to the program.
Pricing details remain unavailable
The specific pricing details states would receive under the federal initiative are not publicly available at this time. Some states are still trying to determine if the new model offers a better deal than existing rebates from drugmakers.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.